drugset / Trial / NCT03260153

Deproteinised Calf Blood Serum Injection for the Treatment of Acute Intracerebral Hemorrhage

NCT03260153 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the efficacy and safety of Deproteinised Calf Blood Serum Injection in alleviating perihematomal edema (PHE) and secondary brain injury, as well as neurologic deficits in patients with acute intracerebral hemorrhage (ICH).

Timeline

Start
2017-01
Primary completion
2018-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Deproteinised Calf Blood Serum Injection Unknown — —